Published in Br J Pharmacol on April 01, 2012
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55. J Biol Chem (2012) 1.05
Atypical regulation of G protein-coupled receptor intracellular trafficking by ubiquitination. Curr Opin Cell Biol (2013) 0.82
The therapeutic potential of orphan GPCRs, GPR35 and GPR55. Front Pharmacol (2015) 0.78
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management. Cancer Manag Res (2013) 0.76
Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol (2011) 10.40
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet (2007) 5.49
Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther (1997) 5.20
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22
Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol (2008) 4.04
Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron (2001) 2.96
Modulation of postendocytic sorting of G protein-coupled receptors. Science (2002) 2.62
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A (2008) 2.42
Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun (2007) 2.18
Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nat Biotechnol (2010) 2.11
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem (2009) 1.91
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J (2008) 1.83
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A (2009) 1.63
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem (2009) 1.60
Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci U S A (2005) 1.55
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain (2008) 1.54
Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol (2008) 1.44
GPR55 ligands promote receptor coupling to multiple signalling pathways. Br J Pharmacol (2010) 1.39
Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1. FASEB J (2006) 1.37
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene (2010) 1.36
Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci (1998) 1.35
Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends Pharmacol Sci (2001) 1.35
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK. Oncogene (2010) 1.32
A molecular basis of analgesic tolerance to cannabinoids. J Neurosci (2007) 1.28
Differential changes in GPR55 during microglial cell activation. FEBS Lett (2009) 1.24
Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther (2010) 1.24
Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine. PLoS One (2010) 1.22
A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br J Pharmacol (2010) 1.21
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res (2011) 1.21
Kinins promote B2 receptor endocytosis and delay constitutive B1 receptor endocytosis. Mol Pharmacol (2006) 1.03
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist. J Pharmacol Exp Ther (2011) 1.03
Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice. Eur J Neurosci (2009) 0.99
The G-protein coupled receptor associated sorting protein GASP-1 regulates the signalling and trafficking of the viral chemokine receptor US28. Traffic (2010) 0.98
Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1. Neuropsychopharmacology (2010) 0.96
G protein-coupled receptor-associated sorting protein 1 regulates the postendocytic sorting of seven-transmembrane-spanning G protein-coupled receptors. Pharmacology (2010) 0.96
Changes in G protein-coupled receptor sorting protein affinity regulate postendocytic targeting of G protein-coupled receptors. J Biol Chem (2007) 0.93
Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55. Adv Pharmacol (2011) 0.89
Identification and biological significance of G protein-coupled receptor associated sorting proteins (GASPs). Pharmacol Ther (2010) 0.89
Dopamine D(3) receptors are down-regulated following heterologous endocytosis by a specific interaction with G protein-coupled receptor-associated sorting protein-1. J Biol Chem (2010) 0.82
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature (2001) 5.65
Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron (2001) 2.96
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Glubran 2: a new acrylic glue for neuroradiological endovascular use. Experimental study on animals. Interv Neuroradiol (2004) 1.51
Some anthropological aspects of the prehistoric Tyrolean ice man. Science (1992) 1.41
[3D computer-assisted ENT biopsies of the Iceman]. HNO (1997) 1.38
Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes Brain Behav (2007) 1.37
Surgical approach to concealed penis: technical refinements and outcome. Urology (2007) 1.27
Gsalpha-selective G protein antagonists. Proc Natl Acad Sci U S A (1998) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Virally encoded 7TM receptors. Oncogene (2001) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Otorhinolaryngologic computer-assisted biopsies of the Iceman. Arch Otolaryngol Head Neck Surg (1997) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet (2000) 1.04
Role of serotoninergic neurones in the control of gonadotrophin and prolactin secretion in the rat. J Endocrinol (1982) 1.03
G protein antagonists. Trends Pharmacol Sci (1999) 1.03
Immortalized luteinizing hormone-releasing hormone neurons show a different migratory activity in vitro. Endocrinology (2000) 1.01
Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis. J Biol Chem (2001) 1.00
Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J Neurochem (2005) 1.00
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
Estrogen receptor is expressed in different types of glial cells in culture. J Neurochem (1994) 0.99
The 5 alpha-reductase in the brain: molecular aspects and relation to brain function. Front Neuroendocrinol (1992) 0.99
A case of dengue type 3 virus infection imported from Africa to Italy, October 2009. Euro Surveill (2010) 0.98
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
Enhanced fluorescence resonance energy transfer between spectral variants of green fluorescent protein through zinc-site engineering. Biochemistry (2001) 0.96
Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones. J Neuroendocrinol (2003) 0.96
Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2013) 0.95
Treatment of venous leg ulcers with sulodexide. Angiology (1999) 0.95
The 5alpha-reductase in the central nervous system: expression and modes of control. J Steroid Biochem Mol Biol (1998) 0.95
Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95
Growth hormone-releasing activity of hypothalamic extracts at different ages. Endocrinology (1965) 0.93
Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content. J Clin Endocrinol Metab (1989) 0.92
Expression of a leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons. Endocrinology (1999) 0.92
A "short" feedback loop in the control of ACTH secretion. Endocrinology (1965) 0.92
[On the segmental arrangement of the liver]. Acta Anat (Basel) (1966) 0.91
Prevalence of nosocomial infections in 15 Italian hospitals: first point prevalance study for the INF-NOS project. Infection (2003) 0.91
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91
Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res (1993) 0.91
Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol (2008) 0.91
Differential localization of the 5 alpha-reductase and the 3 alpha-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology (1993) 0.91
Participation of the amygdala and of the cerebellum in the feedback effects of progesterone. Neuroendocrinology (1973) 0.91
5 alpha-reductase isozymes in the central nervous system. Steroids (1998) 0.90
The 5alpha-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications. Endocr Rev (1982) 0.90
Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145. J Clin Endocrinol Metab (1996) 0.90
Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity. Mol Pharmacol (1999) 0.90
Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90
Transient expression of the 5alpha-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life. Endocrinology (1998) 0.89
Aromatase expression and activity in male and female cultured rat hypothalamic neurons: effect of androgens. Mol Cell Endocrinol (2001) 0.88
The human hypothalamus: a morpho-functional perspective. J Endocrinol Invest (2004) 0.88
[New system for the preservation and storage of anatomical matter]. Acta Anat (Basel) (1978) 0.87
Brain neurotransmitters, amygdala, and control of gonadotropin and prolactin secretion. Adv Biochem Psychopharmacol (1977) 0.87
Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J Neurosci Res (1999) 0.87
Skull of a 5,300-year-old mummy: reproduction and investigation with CT-guided stereolithography. Radiology (1994) 0.86
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2011) 0.86
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.86
Androgen-activating enzymes in the central nervous system. J Steroid Biochem Mol Biol (1999) 0.86
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling. Br J Pharmacol (2014) 0.85
Neuroactive steroids and peripheral myelin proteins. Brain Res Brain Res Rev (2001) 0.85
Effects of steroids on the brain opioid system. J Steroid Biochem Mol Biol (1995) 0.85
The ovariectomized ewe model in the evaluation of biomaterials for prosthetic devices in spinal fixation. Int J Artif Organs (2001) 0.85
Measurement of the B0 production cross section in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2011) 0.85
Search for three-jet resonances in pp collisions at square root(s)=7 TeV. Phys Rev Lett (2011) 0.85
Control of LH secretion: role of a "short" feedback mechanism. Endocrinology (1966) 0.85
Comparison of monoclonal immunocytochemical and immunoenzymatic methods for steroid receptor evaluation in breast cancer. Am J Clin Pathol (1991) 0.85
Systemic lupus erythematosus with pitting oedema of the distal lower limbs. Br J Rheumatol (1998) 0.84
Dimorphic expression of testosterone metabolizing enzymes in the hypothalamic area of developing rats. Brain Res Dev Brain Res (2005) 0.84
5Alpha-reductase type 2 and androgen receptor expression in gonadotropin releasing hormone GT1-1 cells. J Neuroendocrinol (2001) 0.84
Observation of sequential Υ suppression in PbPb collisions. Phys Rev Lett (2012) 0.84
Transforming growth factor-beta and astrocytic conditioned medium influence luteinizing hormone-releasing hormone gene expression in the hypothalamic cell line GT1. Endocrinology (1996) 0.84
G protein coupling of the rat A1-adenosine receptor--partial purification of a protein which stabilizes the receptor-G protein association. Neuropharmacology (1997) 0.84
Oestrogens, via transforming growth factor alpha, modulate basic fibroblast growth factor synthesis in hypothalamic astrocytes: in vitro observations. J Neuroendocrinol (2002) 0.84
Biological assessment of the bone-screw interface after insertion of uncoated and hydroxyapatite-coated pedicular screws in the osteopenic sheep. J Biomed Mater Res A (2003) 0.83
The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin? J Neurocytol (2001) 0.83
Type 1 astrocytes influence luteinizing hormone-releasing hormone release from the hypothalamic cell line GT1-1: is transforming growth factor-beta the principle involved? Endocrinology (1995) 0.83
Biomechanical and histomorphometric investigations on two morphologically differing titanium surfaces with and without fluorohydroxyapatite coating: an experimental study in sheep tibiae. Biomaterials (2003) 0.83
Leptin: a possible link between food intake, energy expenditure, and reproductive function. Regul Pept (2000) 0.83
Effect of polymer molecular weight on the production of drug nanoparticles. J Pharm Sci (2007) 0.83
Metabolic and cytoprotective effects of in vivo peri-patellar hyaluronic acid injections in cultured tenocytes. Connect Tissue Res (2014) 0.82
Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones. Prog Neurobiol (2000) 0.82
[Collet-Sicard syndrome after carotid artery dissection]. Rev Neurol (Paris) (2008) 0.82
[Rudimentary uterus in testicular feminization (author's transl)]. Wien Klin Wochenschr (1975) 0.82
Intrahypothalamic localization of the nuclei synthesizing the gonadotropin releasing factors. J Neurovisc Relat (1971) 0.82
Estrogen, progesterone receptors and proliferating activity evaluated by immunocytochemistry in breast cancer. Int J Biol Markers (1992) 0.82
[Role of lactose, arginine and lysine combination in fracture healing (an experimental study)]. Ann Ital Chir (1996) 0.82
Ultrashort feedback control of luteinizing hormone-releasing hormone secretion in vitro. Endocrinology (1987) 0.82
Steroid binding and metabolism in the luteinizing hormone-releasing hormone-producing neuronal cell line GT1-1. Endocrinology (1994) 0.82
Reserpine and corticotrophin secretion. Acta Endocrinol (Copenh) (1966) 0.82
Gamma-amino-beta-hydroxy butyric acid stimulates prolactin and growth hormone release in normal women. J Clin Endocrinol Metab (1978) 0.82
Identification of type 1 5alpha-reductase in myelin membranes of male and female rat brain. Mol Cell Endocrinol (1997) 0.82
Different diagnostic techniques for the assessment of cortical bone on osteoporotic animals. Biomed Pharmacother (2004) 0.81
Corticosteroid effects on gene expression of myelin basic protein in oligodendrocytes and of glial fibrillary acidic protein in type 1 astrocytes. J Neuroendocrinol (1997) 0.81